Cargando…
Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461616/ https://www.ncbi.nlm.nih.gov/pubmed/37645420 http://dx.doi.org/10.3389/fendo.2023.1258994 |
| _version_ | 1785097873538416640 |
|---|---|
| author | Surmacz, Eva Guarnotta, Valentina Reagan, Michaela Ruth |
| author_facet | Surmacz, Eva Guarnotta, Valentina Reagan, Michaela Ruth |
| author_sort | Surmacz, Eva |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10461616 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104616162023-08-29 Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology Surmacz, Eva Guarnotta, Valentina Reagan, Michaela Ruth Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2023-08-14 /pmc/articles/PMC10461616/ /pubmed/37645420 http://dx.doi.org/10.3389/fendo.2023.1258994 Text en Copyright © 2023 Surmacz, Guarnotta and Reagan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Endocrinology Surmacz, Eva Guarnotta, Valentina Reagan, Michaela Ruth Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology |
| title | Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology |
| title_full | Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology |
| title_fullStr | Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology |
| title_full_unstemmed | Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology |
| title_short | Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology |
| title_sort | editorial: obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology |
| topic | Endocrinology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461616/ https://www.ncbi.nlm.nih.gov/pubmed/37645420 http://dx.doi.org/10.3389/fendo.2023.1258994 |
| work_keys_str_mv | AT surmaczeva editorialobesityandcancerupdateonetiologymolecularbiomarkersandbiotargetsclinicalstrategiesandepidemiology AT guarnottavalentina editorialobesityandcancerupdateonetiologymolecularbiomarkersandbiotargetsclinicalstrategiesandepidemiology AT reaganmichaelaruth editorialobesityandcancerupdateonetiologymolecularbiomarkersandbiotargetsclinicalstrategiesandepidemiology |